Managing Dry Eye in Patients Using Glaucoma Drops

Managing Dry Eye in Patients Using Glaucoma Drops

A single center randomized controlled trial on managing dry eye signs and symptoms in patients using anti-glaucoma eye drops.

To compare the safety and efficacy of IPL therapy on drug-induced dry eye caused by long-term use of anti glaucoma drugs;

Inclusion Criteria:

• Age ≥18 years
• Able and willing to comply with the treatment/follow-up schedule
• Bilateral signs and symptoms of dry eye disease

Exclusion Criteria:

• Participants with systemic immune-mediated illnesses, such as secondary Sjögren's syndrome or graft-versus-host disease
• Patients using topical medication(s) for the treatment of ocular disorders such as allergic conjunctivitis were excluded from the study.
• Previous ocular surgery or trauma
• 1-month history of blepharal and periorbital skin disease or allergies
• Severe dry eyes with corneal epithelial defect
• Limbic keratitis
• Pterygium
• Corneal neovascularization
• Breastfeeding
• Rheumatic immune systemic diseases
• Herpes zoster infection
• Pregnant women
• Allergic to fluorescein
• Contact lens wearers